. . . . . . . "[Therefore, the targeting of the MEK/ERK activity seems to be a promising therapeutic approach to suppressing EMT-associated cancer progression that potentially occurs in TGF?-enriched microenvironments, which would lead to the suppression of the metastatic potential of integrin ?3-positive cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:02+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .